Literature DB >> 16914966

Recent advances in renal tubular calcium reabsorption.

Arjen R Mensenkamp1, Joost G J Hoenderop, René J M Bindels.   

Abstract

PURPOSE OF REVIEW: Knowledge of renal Ca2+ reabsorption has evolved greatly in recent years. This review focuses on two recent discoveries concerning passive and active Ca2+ reabsorption. RECENT
FINDINGS: The thiazide diuretics are known for their hypocalciuric effect. Recently, it has been demonstrated that TRPV5-knockout mice, in which active Ca2+ reabsorption in the distal convoluted tubule is completely abolished, show the same sensitivity towards thiazides as wild-type mice. This indicates that thiazide affects Ca2+ reabsorption indirectly via contraction of the extracellular volume, independent of active Ca2+ reabsorption in the distal convoluted tubule, thereby increasing passive paracellular Ca2+ transport in the proximal tubule. Moreover, the antiaging hormone Klotho regulates Ca2+ reabsorption in the distal convoluted tubule via a novel molecular mechanism. Klotho stabilizes the TRPV5 Ca2+ channel in the plasma membrane by deglycosylation of the protein.
SUMMARY: By showing that thiazide-induced hypercalciuria is due to increased passive Ca2+ reabsorption in the proximal tubule, a long-standing issue has been solved, underlining the importance of proximal paracellular Ca2+ reabsorption. Moreover, the molecular mechanism by which the antiaging hormone Klotho regulates TRPV5 activity may prove to be generally applicable in Klotho-mediated prevention of aging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914966     DOI: 10.1097/01.mnh.0000242179.38739.fb

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  12 in total

1.  Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?

Authors:  M Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2007-10-31       Impact factor: 5.992

Review 2.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

3.  [Disorders of calcium metabolism].

Authors:  C Kasperk; H Bartl
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

4.  Differential Effect of Renal Cortical and Medullary Interstitial Fluid Calcium on Blood Pressure Regulation in Salt-Sensitive Hypertension.

Authors:  Mildred A Pointer; Shaleka Eley; Lauren Anderson; Brittany Waters; Brittany Royall; Sheena Nichols; Candace Wells
Journal:  Am J Hypertens       Date:  2014-12-31       Impact factor: 2.689

Review 5.  Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis.

Authors:  Rajiv Kumar; Volker Vallon
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

Review 6.  Renal control of calcium, phosphate, and magnesium homeostasis.

Authors:  Judith Blaine; Michel Chonchol; Moshe Levi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-06       Impact factor: 8.237

Review 7.  The role of claudin in hypercalciuric nephrolithiasis.

Authors:  Jianghui Hou
Journal:  Curr Urol Rep       Date:  2013-02       Impact factor: 3.092

8.  Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice.

Authors:  Yingben Xue; James C Fleet
Journal:  Gastroenterology       Date:  2008-12-27       Impact factor: 22.682

Review 9.  Biomarker genes for detecting estrogenic activity of endocrine disruptors via estrogen receptors.

Authors:  Eui-Man Jung; Beum-Soo An; Hyun Yang; Kyung-Chul Choi; Eui-Bae Jeung
Journal:  Int J Environ Res Public Health       Date:  2012-02-24       Impact factor: 3.390

10.  Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney.

Authors:  Donald R Dunbar; Hiba Khaled; Louise C Evans; Emad A S Al-Dujaili; Linda J Mullins; John J Mullins; Christopher J Kenyon; Matthew A Bailey
Journal:  Physiol Genomics       Date:  2009-11-17       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.